# | Title | Journal | Year | Citations |
---|
1 | Psychosocial impact of COVID-19 | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 1,215 |
2 | Artificial Intelligence (AI) applications for COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 904 |
3 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 759 |
4 | Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 676 |
5 | Cardiovascular disease and COVID-19 | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 666 |
6 | Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2021 | 658 |
7 | Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 576 |
8 | Long COVID: An overview | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2021 | 516 |
9 | Industry 4.0 technologies and their applications in fighting COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 501 |
10 | Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 500 |
11 | PPAR gamma gene – A review | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2015 | 474 |
12 | Internet of things (IoT) applications to fight against COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 459 |
13 | Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 390 |
14 | Clinical considerations for patients with diabetes in times of COVID-19 epidemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 378 |
15 | Vitamin D concentrations and COVID-19 infection in UK Biobank | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 361 |
16 | Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 357 |
17 | Enhancing immunity in viral infections, with special emphasis on COVID-19: A review | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 356 |
18 | COVID-19 and addiction | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 276 |
19 | A review of modern technologies for tackling COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 256 |
20 | Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2019 | 236 |
21 | Diabetic foot ulcer—A review on pathophysiology, classification and microbial etiology | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2015 | 216 |
22 | Significant applications of virtual reality for COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 210 |
23 | Prevalence of obesity in India: A systematic review | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2019 | 204 |
24 | Obesity and diabetes: An update | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2017 | 194 |
25 | The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes) | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2019 | 192 |
26 | COVID-19 and diabetes mellitus: An unholy interaction of two pandemics | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 190 |
27 | Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 181 |
28 | Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: A systematic review and meta-analysis | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 179 |
29 | Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 174 |
30 | Obesity as a predictor for a poor prognosis of COVID-19: A systematic review | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 168 |
31 | COVID-19 and applications of smartphone technology in the current pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 168 |
32 | Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 167 |
33 | Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 167 |
34 | Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 167 |
35 | Teledentistry during COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 166 |
36 | Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 163 |
37 | Challenges and solutions in meeting up the urgent requirement of ventilators for COVID-19 patients | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 162 |
38 | Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 158 |
39 | Gut microbiome and metabolic syndrome | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2016 | 147 |
40 | Molnupiravir in COVID-19: A systematic review of literature | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2021 | 147 |
41 | Insulin resistance is a cardiovascular risk factor in humans | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2019 | 146 |
42 | Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2018 | 142 |
43 | Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 142 |
44 | Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 141 |
45 | Integrating emerging technologies into COVID-19 contact tracing: Opportunities, challenges and pitfalls | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 141 |
46 | Diabetes self-management amid COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 140 |
47 | Application of cognitive Internet of Medical Things for COVID-19 pandemic | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 139 |
48 | Burden of non-communicable disease: Global overview | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2010 | 136 |
49 | Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2017 | 136 |
50 | Impact of COVID-19 on lifestyle-related behaviours- a cross-sectional audit of responses from nine hundred and ninety-five participants from India | Diabetes and Metabolic Syndrome: Clinical Research and Reviews | 2020 | 133 |